Search research articles
Contact Us
Filters
Showing results (101-110 of 117) with videos related to
Page
of 12
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2020
VA-Radiation Oncology Quality Surveillance Program
Michael Hagan, Rishabh Kapoor, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2012
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
Hiram A Gay, H Joseph Barthold, Elizabeth O'Meara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
The Journal of Urology
|
September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop
Chana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2007
Prostate cancer. Clinical practice guidelines in oncology
James Mohler, Richard J Babaian, Robert R Bahnson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)
Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Practical Radiation Oncology
|
June 11, 2022
Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative
John Park, Lindsay L Puckett, Evangelia Katsoulakis, et al.
Virchows Archiv : an International Journal of Pathology
|
October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Pathology
|
December 5, 2014
Active surveillance for prostate cancer: the role of the pathologist
Brett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
The Lancet. Oncology
|
March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Laila A Gharzai, Ralph Jiang, David Wallington, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 117) with videos related to
Sort By:
Page
of 12
International Journal of Radiation Oncology, Biology, Physics
|
January 28, 2020
VA-Radiation Oncology Quality Surveillance Program
Michael Hagan, Rishabh Kapoor, Jeff Michalski, et al.
International Journal of Radiation Oncology, Biology, Physics
|
April 10, 2012
Pelvic normal tissue contouring guidelines for radiation therapy: a Radiation Therapy Oncology Group consensus panel atlas
Hiram A Gay, H Joseph Barthold, Elizabeth O'Meara, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 20, 2020
Event-Free Survival, a Prostate-Specific Antigen-Based Composite End Point, Is Not a Surrogate for Overall Survival in Men With Localized Prostate Cancer Treated With Radiation
Wanling Xie, Meredith M Regan, Marc Buyse, et al.
The Journal of Urology
|
September 11, 2019
Development of Treatments for Localized Prostate Cancer in Patients Eligible for Active Surveillance: U.S. Food and Drug Administration Oncology Center of Excellence Public Workshop
Chana Weinstock, Daniel Suzman, Paul Kluetz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
August 19, 2007
Prostate cancer. Clinical practice guidelines in oncology
James Mohler, Richard J Babaian, Robert R Bahnson, et al.
International Journal of Radiation Oncology, Biology, Physics
|
July 25, 2025
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115)
Daniel A Hamstra, James J Dignam, Deborah W Bruner, et al.
Practical Radiation Oncology
|
June 11, 2022
Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative
John Park, Lindsay L Puckett, Evangelia Katsoulakis, et al.
Virchows Archiv : an International Journal of Pathology
|
October 16, 2014
Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist
Rodolfo Montironi, Elizabeth H Hammond, Daniel W Lin, et al.
Pathology
|
December 5, 2014
Active surveillance for prostate cancer: the role of the pathologist
Brett Delahunt, Elizabeth Hammond, Lars Egevad, et al.
The Lancet. Oncology
|
March 4, 2021
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Laila A Gharzai, Ralph Jiang, David Wallington, et al.
Page
of 12